Barclays stays at ‘equalweight’ on Ultra Electronics, says backlog growth already priced in

by | Mar 16, 2021

Analysts at Barclays stuck to their ‘equalweight’ recommendation for shares of Ultra Electronics, despite what they termed the defence specialist’s “solid” full-year performance across 2020.
In their opinion, the shares’ premium rating versus defence peers in the European Union meant that “upside” from backlog growth had already been priced in.

Furthermore, while they upped their 2022-23 earnings per share estimates by 5%, cash was expected to be subdued on account of the firm’s investment activity.

Hence their stated preference for outsized EPS and free cash flow growth elsewhere in the sector, in names such BAE Systems, Qinetiq or Chemring.

Their 2,200.0p target price was unchanged as well, with the stock trading at an estimated 23% premium versus EU defence peers on 2022 EV/EBIT basis, Barclays said.

The broker also pointed out the strong performance seen in the company’s Maritime end markets, a reflection of the heightened underwater threat environment.

Related articles

RBC Capital cuts Rentokil price target

RBC Capital cuts Rentokil price target

(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!

x